Search Results - "Marty, Francisco M"

Refine Results
  1. 1

    New Perspectives on Antimicrobial Agents: Remdesivir Treatment for COVID-19 by Aleissa, Muneerah M, Silverman, Emily A, Paredes Acosta, Luisa M, Nutt, Cameron T, Richterman, Aaron, Marty, Francisco M

    Published in Antimicrobial agents and chemotherapy (16-12-2020)
    “…Remdesivir was recently approved by the Food and Drug Administration for the treatment of hospitalized patients with coronavirus disease 2019 (COVID-19)…”
    Get full text
    Journal Article
  2. 2
  3. 3

    A Breath Fungal Secondary Metabolite Signature to Diagnose Invasive Aspergillosis by Koo, Sophia, Thomas, Horatio R., Daniels, S. David, Lynch, Robert C., Fortier, Sean M., Shea, Margaret M., Rearden, Preshious, Comolli, James C., Baden, Lindsey R., Marty, Francisco M.

    Published in Clinical infectious diseases (15-12-2014)
    “…Background. Invasive aspergillosis (IA) remains a leading cause of mortality in immunocompromised patients, in part due to the difficulty of diagnosing this…”
    Get full text
    Journal Article
  4. 4

    Diagnostic Performance of the (1→3)-β-d-Glucan Assay for Invasive Fungal Disease by Koo, Sophia, Bryar, Julie M., Page, John H., Baden, Lindsey R., Marty, Francisco M.

    Published in Clinical infectious diseases (01-12-2009)
    “…Background.Diagnosis of invasive fungal disease (IFD) is challenging, and it remains a significant cause of morbidity and mortality in immunocompromised…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation by Chen, Kaiwen, Cheng, Matthew P., Hammond, Sarah P., Einsele, Hermann, Marty, Francisco M.

    Published in Blood advances (28-08-2018)
    “…Patients treated with allogeneic hematopoietic cell transplantation (HCT) are at risk of cytomegalovirus (CMV) reactivation and disease, which results in…”
    Get full text
    Journal Article
  8. 8

    Molecular Methods To Improve Diagnosis and Identification of Mucormycosis by HAMMOND, Sarah P, BIALEK, Ralf, MILNER, Danny A, PETSCHNIGG, Eva M, BADEN, Lindsey R, MARTY, Francisco M

    Published in Journal of Clinical Microbiology (01-06-2011)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  9. 9

    Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia by Fung, Monica, Kim, Jane, Marty, Francisco M, Schwarzinger, Michaël, Koo, Sophia

    Published in PloS one (10-11-2015)
    “…Invasive fungal disease (IFD) causes significant morbidity and mortality in hematologic malignancy patients with high-risk febrile neutropenia (FN). These…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Breakthrough Zygomycosis after Voriconazole Treatment in Recipients of Hematopoietic Stem-Cell Transplants by Baden, Lindsey R, Marty, Francisco M, Cosimi, Lisa A

    Published in The New England journal of medicine (26-02-2004)
    “…To the Editor: The Food and Drug Administration (FDA) approved voriconazole for the treatment of invasive aspergillosis partly on the basis of data published…”
    Get full text
    Journal Article
  13. 13

    Risk of Latent Tuberculosis Reactivation After Hematopoietic cell Transplantation by Cheng, Matthew P, Kusztos, Amanda E, Bold, Tyler D, Ho, Vincent T, Glotzbecker, Brett E, Hsieh, Candace, Baker, Meghan A, Baden, Lindsey R, Hammond, Sarah P, Marty, Francisco M

    Published in Clinical infectious diseases (16-08-2019)
    “…Abstract There were no cases of tuberculosis in a cohort of 2531 patients who underwent hematopoietic cell transplantation from 2010 to 2015 after 7323…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Isavuconazole Treatment of a Patient with Disseminated Mucormycosis by Peixoto, Driele, Gagne, Lisa S, Hammond, Sarah P, Gilmore, Erin T, Joyce, Amy C, Soiffer, Robert J, Marty, Francisco M

    Published in Journal of Clinical Microbiology (01-03-2014)
    “…Classifications Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  16. 16

    Prognostic Features of Galactomannan Antigenemia in Galactomannan-Positive Invasive Aspergillosis by Koo, Sophia, Bryar, Julie M, Baden, Lindsey R, Marty, Francisco M

    Published in Journal of Clinical Microbiology (01-04-2010)
    “…Prognostic features of serum galactomannan (GM) remain poorly defined in patients with GM-positive invasive aspergillosis (GPA). We identified 93 patients with…”
    Get full text
    Journal Article
  17. 17

    Infectious Complications Associated with Alemtuzumab Use for Lymphoproliferative Disorders by Martin, Stanley I., Marty, Francisco M., Fiumara, Karen, Treon, Steven P., Gribben, John G., Baden, Lindsey R.

    Published in Clinical infectious diseases (01-07-2006)
    “…Background. Alemtuzumab is an emerging therapy for refractory lymphoproliferative disorders. The associated long-term risks of infection remain poorly defined…”
    Get full text
    Journal Article
  18. 18

    Mortality in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients with Mucormycosis, 2001 to 2009 by HAMMOND, Sarah P, BADEN, Lindsey R, MARTY, Francisco M

    Published in Antimicrobial Agents and Chemotherapy (01-11-2011)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  19. 19

    How to Obtain a Nasopharyngeal Swab Specimen by Marty, Francisco M, Chen, Kaiwen, Verrill, Kelly A

    Published in The New England journal of medicine (28-05-2020)
    “…Collecting specimens from the surface of the respiratory mucosa with nasopharyngeal swabs is a procedure used to diagnose Covid-19 as well as other respiratory…”
    Get full text
    Journal Article
  20. 20

    Dasatinib Use and Risk of Cytomegalovirus Reactivation After Allogeneic Hematopoietic-Cell Transplantation by Prestes, Daniel P., Arbona, Esther, Nevett-Fernandez, Alexandra, Woolley, Ann E., Ho, Vincent T., Koo, Sophia, Baden, Lindsey R., Koreth, John, Hammond, Sarah P., Issa, Nicolas C., Marty, Francisco M.

    Published in Clinical infectious diseases (01-08-2017)
    “…Viral infections have been reported with dasatinib use, but its cytomegalovirus risk after hematopoietic-cell transplantation (HCT) is not known. We found that…”
    Get full text
    Journal Article